Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200469508> ?p ?o ?g. }
Showing items 1 to 77 of
77
with 100 items per page.
- W4200469508 endingPage "e27923" @default.
- W4200469508 startingPage "e27923" @default.
- W4200469508 abstract "The aim of this study was to evaluate the efficacy and safety of bismuth pectin capsules and bismuth pectin granules in the first-line quadruple treatment of Helicobacter pylori (H. pylori).This study was a multicenter, randomized, open-labelled controlled clinical trial. Patients with a H. pylori infection were randomized into 4 groups (1:1:1:1) and treated with a 14-day bismuth-containing quadruple therapy. The 4 groups received either bismuth potassium citrate capsules (220 mg), colloidal bismuth pectin capsules (200 mg), bismuth pectin granules (150 mg), or bismuth pectin granules (300 mg). The primary outcome was the eradication rate of H. pylori. The secondary outcomes included symptom improvement, patient compliance, and incidence of adverse events. This study was registered at ClinicalTrials.gov (NCT04209933).A total of 240 patients were included in this study, and 211 patients completed the follow-up. An intention-to-treat analysis showed that the H. pylori eradication rates of the 4 groups were 73.3%, 76.7%, 75.0%, and 71.7%, respectively. The per-protocol analysis showed that the H. pylori eradication rates of the 4 groups were 86.3%, 82.1%, 83.3%, and 86.0%. There was no significant difference among the 4 groups in the H. pylori eradication rate (P > .05). There were also no significant differences in the symptom improvement rate, overall adverse reaction rate, or patient compliance among the 4 groups.Bismuth pectin capsules and bismuth pectin granules had similar efficacy and safety for H. pylori eradication compared to bismuth potassium citrate. These data suggest that bismuth pectin can be an alternative to bismuth potassium citrate to eradicate H. pylori when using bismuth-containing quadruple therapy." @default.
- W4200469508 created "2021-12-31" @default.
- W4200469508 creator A5011225601 @default.
- W4200469508 creator A5029484872 @default.
- W4200469508 creator A5030809161 @default.
- W4200469508 creator A5033983569 @default.
- W4200469508 creator A5040694387 @default.
- W4200469508 creator A5042843937 @default.
- W4200469508 creator A5046214153 @default.
- W4200469508 creator A5057060669 @default.
- W4200469508 creator A5057209439 @default.
- W4200469508 creator A5066448012 @default.
- W4200469508 creator A5075877965 @default.
- W4200469508 creator A5080125836 @default.
- W4200469508 date "2021-12-17" @default.
- W4200469508 modified "2023-10-17" @default.
- W4200469508 title "The efficacy and safety of different bismuth agents in Helicobacter pylori first-line eradication: A multicenter, randomized, controlled clinical trial." @default.
- W4200469508 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34918639" @default.
- W4200469508 hasPublicationYear "2021" @default.
- W4200469508 type Work @default.
- W4200469508 citedByCount "2" @default.
- W4200469508 countsByYear W42004695082023 @default.
- W4200469508 crossrefType "journal-article" @default.
- W4200469508 hasAuthorship W4200469508A5011225601 @default.
- W4200469508 hasAuthorship W4200469508A5029484872 @default.
- W4200469508 hasAuthorship W4200469508A5030809161 @default.
- W4200469508 hasAuthorship W4200469508A5033983569 @default.
- W4200469508 hasAuthorship W4200469508A5040694387 @default.
- W4200469508 hasAuthorship W4200469508A5042843937 @default.
- W4200469508 hasAuthorship W4200469508A5046214153 @default.
- W4200469508 hasAuthorship W4200469508A5057060669 @default.
- W4200469508 hasAuthorship W4200469508A5057209439 @default.
- W4200469508 hasAuthorship W4200469508A5066448012 @default.
- W4200469508 hasAuthorship W4200469508A5075877965 @default.
- W4200469508 hasAuthorship W4200469508A5080125836 @default.
- W4200469508 hasConcept C126322002 @default.
- W4200469508 hasConcept C168563851 @default.
- W4200469508 hasConcept C178790620 @default.
- W4200469508 hasConcept C185592680 @default.
- W4200469508 hasConcept C197934379 @default.
- W4200469508 hasConcept C2776409635 @default.
- W4200469508 hasConcept C2780756937 @default.
- W4200469508 hasConcept C31903555 @default.
- W4200469508 hasConcept C533668322 @default.
- W4200469508 hasConcept C535046627 @default.
- W4200469508 hasConcept C71924100 @default.
- W4200469508 hasConcept C90924648 @default.
- W4200469508 hasConceptScore W4200469508C126322002 @default.
- W4200469508 hasConceptScore W4200469508C168563851 @default.
- W4200469508 hasConceptScore W4200469508C178790620 @default.
- W4200469508 hasConceptScore W4200469508C185592680 @default.
- W4200469508 hasConceptScore W4200469508C197934379 @default.
- W4200469508 hasConceptScore W4200469508C2776409635 @default.
- W4200469508 hasConceptScore W4200469508C2780756937 @default.
- W4200469508 hasConceptScore W4200469508C31903555 @default.
- W4200469508 hasConceptScore W4200469508C533668322 @default.
- W4200469508 hasConceptScore W4200469508C535046627 @default.
- W4200469508 hasConceptScore W4200469508C71924100 @default.
- W4200469508 hasConceptScore W4200469508C90924648 @default.
- W4200469508 hasIssue "50" @default.
- W4200469508 hasOpenAccess W4200469508 @default.
- W4200469508 hasRelatedWork W10740235 @default.
- W4200469508 hasRelatedWork W12776443 @default.
- W4200469508 hasRelatedWork W13626767 @default.
- W4200469508 hasRelatedWork W14018207 @default.
- W4200469508 hasRelatedWork W14835231 @default.
- W4200469508 hasRelatedWork W16975054 @default.
- W4200469508 hasRelatedWork W1922612 @default.
- W4200469508 hasRelatedWork W2103191 @default.
- W4200469508 hasRelatedWork W6080974 @default.
- W4200469508 hasRelatedWork W7244361 @default.
- W4200469508 hasVolume "100" @default.
- W4200469508 isParatext "false" @default.
- W4200469508 isRetracted "false" @default.
- W4200469508 workType "article" @default.